GENETIC TESTS USED TODAY TO DETECT GENE VARIANTS ASSOCIATED WITH CERTAIN DISEASES OR CONDITIONS APPLY A TARGETED APPROACH THAT ALLOWS FOR THE ANALYSIS OF A LIMITED PORTION OF THE GENOME. THIS WILL BE REDUCED BY 90 % OF ANY CLINICALLY RELEVANT VARIANT. AS A CONSEQUENCE OF THIS, THIS IS AN EXTREMELY COMPLEX, INEFFICIENT AND LOW-PERFORMING DIAGNOSTIC PROCESS. CIò SHALL LEAD TO A SIGNIFICANT LENGTHENING OF TIME LIMITS FOR ACCURATELY OBTAINING THE CORRECT DIAGNOSIS AND FOR TREATMENT TO BE ADJUSTED.